ArticleBMC microbiology2026
CgCFEM1 and CgCFEM2 modulate virulence in Colletotrichum gloeosporioides by integrated regulation of TOR and cAMP-PKA signaling pathways.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundColletotrichum gloeosporioides causes anthracnose in multiple plants via specialized infection structures, which are regulated by conserved pathways including the Target of rapamycin (TOR) and cyclic adenosine monophosphate-protein kinase A (cAMP-PKA). Effectors with Common in Fungal Extracellular Membranes (CFEM) domain are critical virulence factors. Although CgCFEM1 has been characterized, the role of its closest homolog CgCFEM2 and their potential interplay remains unknown.
resultsThis study demonstrates that CgCFEM2 is a crucial pathogenicity effector, with its gene expression highly induced during infection. Pathogenicity assays on rubber tree leaves revealed that the ΔCgCFEM2 mutant was severely attenuated in virulence, and the double mutant ΔCgCFEM1/2 exhibited an even more severe defect, indicating CgCFEM1 and CgCFEM2 play complementary yet distinct roles in pathogenicity. Both effectors were essential for normal conidia morphology, conidiation, and the critical transition from appressoria to invasive hyphae. Mechanistically, we discovered that loss of CgCFEM1 and CgCFEM2 leads to deregulated cell cycle progression during infection-related development, resulting in aberrant germ tube elongation and impaired appressorium formation. Additionally, the mutants exhibited hyperactive phosphorylation of p70-S6 kinase (p70 S6K) and insensitivity to rapamycin, indicating the involvement of TOR signaling. A key finding is that both CgCFEM1 and CgCFEM2 positively regulate intracellular cAMP levels, but through fundamentally distinct targets: CgCFEM1 promotes cAMP synthesis by upregulating the adenylate cyclase gene CgMac1, whereas CgCFEM2 inhibits cAMP degradation by repressing the phosphodiesterase gene CgPdeH. Consequently, the loss of these effectors led to reduced cAMP levels and impaired phosphorylation of MAP kinase Pmk1.
conclusionsOur findings establish that CgCFEM1 and CgCFEM2 as pivotal, synergistic regulators of the C. gloeosporioides infection cycle. They converge on elevating cAMP levels via different mechanisms: synthesis versus degradation. They also influence TOR signaling. Together, they ensure proper fungal development and pathogenicity. This study provides novel insights into the sophisticated effector network employed by phytopathogenic fungi to achieve successful infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.